3Claven PA, Harvey PRC, Strasberg SM, et al. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies [ J ]. Transplantation, 1992 , 53 ( 5 ) :957-978.
4Ploeg RJ, D' Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation multivariate analysis [ J ]. Transplantation, 2008 , 55 ( 4 ) : 807-813.
5Rentsrh M, Beham A, Sirek S, et al. Glycine but not sadolinium chloride or methyl palmitate reduces postischemic white hlood cell accumulation and early grati nonfunction after liver transplantation in the rat [ J ]. Transplant Proc, 2009 , 34 ( 6 ) : 2389-2390.
6Tanonaka K,Iwai Motegi K,et al. Effects of N-(2-mer- captopropionyl)- glycine on mitochondrial function in ischemic- reperfused heart [ J ]. Cardiovasc Res, 2006 , 57 (5) :416-425.
7Omasa M, Fukuse T,Toyokuni S,et al. Glycine ameliorates lung reperfusion injury after cold preservation in an ex vivo rat lung model [ J ]. Tranplantation, 2008 , 75 ( 8 ) : 591 -598.
9Wheeler MD, Ikejema K, Enomoto N, et al. L- Glycine : a lovel antiilfflammatory, immunomodulatory, and cytopro- ective agent [ J ]. Cell MoILifesei, 2006 ,$6 ( 3 ) : 843-856.
10Michael W, Robert F, Shunhei Y, et al. Predicting treatment response during the acute phase of hospitalization [ J ]. FASEB J, 2008 , 14 ( 3 ) :476-484.
